130 related articles for article (PubMed ID: 6724230)
1. Pharmacokinetics of human recombinant interferon-beta in monkeys and rabbits.
Gomi K; Morimoto M; Inoue A; Kobayashi H; Deguchi T; Hara T; Nakamizo N
Gan; 1984 Mar; 75(3):292-300. PubMed ID: 6724230
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effect of human recombinant interferon-beta against human melanomas transplanted into nude mice.
Gomi K; Morimoto M; Nakamizo N
J Pharmacobiodyn; 1984 Dec; 7(12):951-61. PubMed ID: 6533284
[TBL] [Abstract][Full Text] [Related]
3. Growth-inhibitory activity of recombinant human interferon-beta against cultured human cells.
Gomi K; Morimoto M; Nakamizo N
Gan; 1983 Oct; 74(5):737-42. PubMed ID: 6642144
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics of human interferons].
Furue H; Kobayashi H; Komuro T; Kako M; Mugitani H; Fuse K; Kaise R; Nagai K; Takahashi T; Hirota F
Gan To Kagaku Ryoho; 1984 Apr; 11(4):935-42. PubMed ID: 6721508
[TBL] [Abstract][Full Text] [Related]
5. Circulating interferon in rabbits and monkeys after administration of human gamma interferon by different routes.
Cantell K; Hirvonen S; Pyhälä L; De Reus A; Schellekens H
J Gen Virol; 1983 Aug; 64 (Pt 8)():1823-6. PubMed ID: 6409993
[TBL] [Abstract][Full Text] [Related]
6. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
Okabe M; Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
[TBL] [Abstract][Full Text] [Related]
7. Immune-enhancing effect of recombinant human interferon-beta produced in Escherichia coli on human peripheral blood mononuclear cells in vitro.
Okabe M; Morimoto M; Nakamizo N
Gan; 1983 Oct; 74(5):743-50. PubMed ID: 6357933
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.
Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Mar; 76(3):224-34. PubMed ID: 3922841
[TBL] [Abstract][Full Text] [Related]
9. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
Gomi K; Akinaga S; Oka T; Morimoto M
Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
[TBL] [Abstract][Full Text] [Related]
10. Different kinetics of antiviral and anticellular activities between human recombinant and natural interferon-gamma arising from different receptor-binding properties.
Gomi K; Akinaga S; Inoue A; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1986 Sep; 77(9):946-55. PubMed ID: 3095289
[TBL] [Abstract][Full Text] [Related]
11. Different pharmacokinetics between natural and recombinant human interferon beta in rabbits.
Satoh YI; Kasama K; Kajita A; Shimizu H; Ida N
J Interferon Res; 1984; 4(3):411-22. PubMed ID: 6491398
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of human recombinant interferon-gamma and -beta against human osteosarcoma transplanted into nude mice.
Gomi K; Oka T; Morimoto M
J Pharmacobiodyn; 1986 Nov; 9(11):879-88. PubMed ID: 3104572
[TBL] [Abstract][Full Text] [Related]
13. Synergistic anticellular and antiviral activities of human recombinant interferon-gamma and -beta.
Gomi K; Kimura H; Okabe M; Oka T; Morimoto M
J Pharmacobiodyn; 1986 Nov; 9(11):871-8. PubMed ID: 3031263
[TBL] [Abstract][Full Text] [Related]
14. Characterization of receptors for human recombinant interferon-gamma in human cells.
Akinaga S; Gomi K; Oka T; Morimoto M
J Pharmacobiodyn; 1987 Jun; 10(6):272-9. PubMed ID: 2959767
[TBL] [Abstract][Full Text] [Related]
15. [Interferons--its method of administration and adverse effect related to pharmacokinetics ].
Furue H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of human lymphoblastoid interferon in rabbits.
Bocci V; Pessina GP; Pacini A; Paulesu L; Muscettola M; Naldini A; Lunghetti G
Gen Pharmacol; 1985; 16(3):277-9. PubMed ID: 4018543
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of recombinant interferon alpha-C.
Merimsky O; Rubinstein M; Fischer D; Danon A; Chaitchik S
Cancer Chemother Pharmacol; 1991; 27(5):406-8. PubMed ID: 1999003
[TBL] [Abstract][Full Text] [Related]
18. Plasma levels following intranasal and intravenous administration of human interferon-beta to rabbits.
Maitani Y; Igawa T; Machida Y; Nagai T
Drug Des Deliv; 1989 Mar; 4(2):109-19. PubMed ID: 2765103
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of recombinant human interferon-gamma in the rhesus monkey after intravenous, intramuscular, and subcutaneous administration.
Ferraiolo BL; Fuller GB; Burnett B; Chan E
J Biol Response Mod; 1988 Apr; 7(2):115-22. PubMed ID: 3129541
[TBL] [Abstract][Full Text] [Related]
20. The lymphatic route--III. Pharmacokinetics of human natural interferon-beta injected with albumin as a retarder in rabbits.
Bocci V; Muscettola M; Naldini A
Gen Pharmacol; 1986; 17(4):445-8. PubMed ID: 3758650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
